Extended Data Fig. 7: Full distributions of Cognitive outcomes grouped by Braak stage.
From: Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Group means are represented by lines, error bars indicate standard deviation where applicable. a: n = 292 individuals with neuropsychological assessments available. b: n = 324 individuals with summary cognitive assessments available. c: n = 14 PSEN1 mutation carriers; total of 21 scans including follow-ups.
